New BDO CRO Insights Report reveals high rate of CRA turnover and what organizations are doing to combat it.
Andy Studna, Senior Editor
Advertisement
Articles by Andy Studna, Senior Editor
Co-conveners of the newly formed Decentralized Trials & Research Alliance, Amir Kalali, MD and Craig Lipset discuss the alliance as well as how COVID-19 has impacted the industry.
Recent webcast addresses what organizations can do to prepare for the next revision of ICH E6.
EVP and General Manager of Hū, April Lewis, discusses why the industry has seen a decline in trial participation and what Hū is doing to combat it.
Sujay Jadhav, global vice president, study start-up, Oracle Health Sciences, spoke with ACT on how study start-up has been impacted by the pandemic and what its future holds beyond COVID.
Jody Casey of Elligo Health Research gives insight into the issue of diversity in trials and what needs to be done to correct it.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Reportedly Pauses Commissioner’s National Priority Voucher Pilot as Existing Reviews Continue
2
How Inconsistent Screening Shapes Which Oncology Patients Get Flagged for Trials
3
ACT Brief: Zip Code Trial Access, Smaller Biotech APAC Perceptions, and Pimjetmi Tumor Approval
4
What Smaller Biotechs Need to Get Right in Their First APAC Phase III Trial
5